1819 Innovation Hub tenant inks key partnership with Korea VC firm

The following excerpt was taken from TechOhio-- continue reading here.

A biotech firm that moved its headquarters from New York to Cincinnati in late 2021 has announced its first major collaboration since planting roots in the Queen City, and officials said the deal will help fuel faster international growth.

Orange Grove Bio, a preclinical drug investment and development firm based at University of Cincinnati’s 1819 Innovation Hub, announced a new partnership Tuesday with SV Investment, a Seoul, Korea-based venture capital and private equity firm. The companies said the partnership will allow them to collaborate on jointly sourcing and developing new therapeutics in the U.S. and East Asia.